Artigos de revistas sobre o tema "Cxcr1-2"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Cxcr1-2".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Zhang, Jing, Shouguo Huang, Lini Quan, Qiu Meng, Haiyan Wang, Jie Wang e Jin Chen. "Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis". BioMed Research International 2021 (19 de março de 2021): 1–13. http://dx.doi.org/10.1155/2021/8883800.
Texto completo da fonteDoroshenko, Tatyana, Yuri Chaly, Valery Savitskiy, Olga Maslakova, Anna Portyanko, Irina Gorudko e Nikolai N. Voitenok. "Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2". Blood 100, n.º 7 (1 de outubro de 2002): 2668–71. http://dx.doi.org/10.1182/blood.100.7.2668.
Texto completo da fonteKonrad, F. M., e J. Reutershan. "CXCR2 in Acute Lung Injury". Mediators of Inflammation 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/740987.
Texto completo da fonteFeniger-Barish, Rotem, Dan Belkin, Alon Zaslaver, Shira Gal, Mally Dori, Maya Ran e Adit Ben-Baruch. "GCP-2–induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR+-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling". Blood 95, n.º 5 (1 de março de 2000): 1551–59. http://dx.doi.org/10.1182/blood.v95.5.1551.005a36_1551_1559.
Texto completo da fonteSmithson, Alex, Maria Rosa Sarrias, Juanjo Barcelo, Belen Suarez, Juan Pablo Horcajada, Sara Maria Soto, Alex Soriano et al. "Expression of Interleukin-8 Receptors (CXCR1 and CXCR2) in Premenopausal Women with Recurrent Urinary Tract Infections". Clinical Diagnostic Laboratory Immunology 12, n.º 12 (dezembro de 2005): 1358–63. http://dx.doi.org/10.1128/cdli.12.12.1358-1363.2005.
Texto completo da fonteMolczyk, Caitlin, e Rakesh K. Singh. "CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors". Biomedicines 11, n.º 2 (16 de fevereiro de 2023): 576. http://dx.doi.org/10.3390/biomedicines11020576.
Texto completo da fonteNgo, Hai, Evdoxia Hatjiharissi, Xavier Leleu, Judith Runnels, Anne-Sophie Moreau, Xiaoying Jia, Garrett O’Sullivan et al. "The CXCR4/SDF-1 Axis Regulates Migration and Adhesion in Waldenstrom Macroglobulinemia." Blood 108, n.º 11 (1 de novembro de 2006): 2418. http://dx.doi.org/10.1182/blood.v108.11.2418.2418.
Texto completo da fonteKhandaker, Masud H., Luoling Xu, Rahbar Rahimpour, Gordon Mitchell, Mark E. DeVries, J. Geoffrey Pickering, Sharwan K. Singhal, Ross D. Feldman e David J. Kelvin. "CXCR1 and CXCR2 Are Rapidly Down-Modulated by Bacterial Endotoxin Through a Unique Agonist-Independent, Tyrosine Kinase-Dependent Mechanism". Journal of Immunology 161, n.º 4 (15 de agosto de 1998): 1930–38. http://dx.doi.org/10.4049/jimmunol.161.4.1930.
Texto completo da fonteVacchini, Alessandro, Anneleen Mortier, Paul Proost, Massimo Locati, Mieke Metzemaekers e Elena Borroni. "Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties". International Journal of Molecular Sciences 19, n.º 12 (27 de novembro de 2018): 3768. http://dx.doi.org/10.3390/ijms19123768.
Texto completo da fonteBurton, Victoria J., Alan M. Holmes, Loredana I. Ciuclan, Alexander Robinson, Jan S. Roger, Gabor Jarai, Andrew C. Pearce e David C. Budd. "Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II". Blood 118, n.º 17 (27 de outubro de 2011): 4750–58. http://dx.doi.org/10.1182/blood-2011-05-347393.
Texto completo da fonteBrowning, Darren D., Wade C. Diehl, Matthew H. Hsu, Ingrid U. Schraufstatter e Richard D. Ye. "Autocrine regulation of interleukin-8 production in human monocytes". American Journal of Physiology-Lung Cellular and Molecular Physiology 279, n.º 6 (1 de dezembro de 2000): L1129—L1136. http://dx.doi.org/10.1152/ajplung.2000.279.6.l1129.
Texto completo da fonteInngjerdingen, Marit, Bassam Damaj e Azzam A. Maghazachi. "Expression and regulation of chemokine receptors in human natural killer cells". Blood 97, n.º 2 (15 de janeiro de 2001): 367–75. http://dx.doi.org/10.1182/blood.v97.2.367.
Texto completo da fontede Jong, Madelon M. E., Cathelijne Fokkema, Natalie Papazian, Sabrin Tahri, Zoltan Kellermayer, Michael Vermeulen, Mark van Duin et al. "Inflammasome-Primed Myeloid Cells Maintain a Pro-Tumor Microenvironment in Multiple Myeloma". Blood 138, Supplement 1 (5 de novembro de 2021): 2679. http://dx.doi.org/10.1182/blood-2021-150327.
Texto completo da fonteTroppan, Katharina, Kerstin Wenzl, Peter Neumeister, Christine Beham-Schmid, Martina Przekopowitz, Hildegard T. Greinix, Helmut Schaider e Alexander JA Deutsch. "The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome". Blood 126, n.º 23 (3 de dezembro de 2015): 3890. http://dx.doi.org/10.1182/blood.v126.23.3890.3890.
Texto completo da fonteTeijeira, Alvaro, Saray Garasa, Itziar Migueliz, Assunta Cirella e Ignacio Melero. "755 CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (novembro de 2020): A803. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0755.
Texto completo da fonteBie, Yaqin, Wei Ge, Zhibin Yang, Xianshuo Cheng, Zefeng Zhao, Shengjie Li, Wenchao Wang et al. "The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis". Disease Markers 2019 (20 de novembro de 2019): 1–12. http://dx.doi.org/10.1155/2019/8023460.
Texto completo da fonteUllman, Nicholas A., Luis I. Ruffolo, Katherine M. Jackson, Alexander Chacon, Mary Georger, Rachel Jewell, Brian A. Belt, Dean Maeda, John Zebala e David Linehan. "CXCR1/2 blockade to enhance response to immune checkpoint inhibition in an aggressive orthotopic pancreatic adenocarcinoma model." Journal of Clinical Oncology 38, n.º 5_suppl (10 de fevereiro de 2020): 19. http://dx.doi.org/10.1200/jco.2020.38.5_suppl.19.
Texto completo da fonteMolczyk, Caitlin, Elizabeth Thomas, Lubaba Zaman, Paran Goel e Rakesh K. Singh. "Abstract 894: CXCR1: A novel therapeutic avenue for CSC-like phenotypes in pancreatic ductal adenocarcinoma". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 894. http://dx.doi.org/10.1158/1538-7445.am2022-894.
Texto completo da fonteStadlbauer, V., R. P. Mookerjee, G. A. K. Wright, N. A. Davies, G. Jürgens, S. Hallström e R. Jalan. "Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis". American Journal of Physiology-Gastrointestinal and Liver Physiology 296, n.º 1 (janeiro de 2009): G15—G22. http://dx.doi.org/10.1152/ajpgi.90512.2008.
Texto completo da fonteTakata, Hiroshi, Takuya Naruto e Masafumi Takiguchi. "Functional heterogeneity of human effector CD8+ T cells". Blood 119, n.º 6 (9 de fevereiro de 2012): 1390–98. http://dx.doi.org/10.1182/blood-2011-03-343251.
Texto completo da fonteМурашко, Д. И., А. Д. Таганович e Н. Н. Ковганко. "Combined Determination of CXCR1, CXCR2, Hyaluronic Acid and CYFRA 21-1 Receptors in the Blood in the Diagnosis of Non-Small Cell Lung Cancer". Евразийский онкологический журнал, n.º 3 (1 de novembro de 2022): 201–16. http://dx.doi.org/10.34883/pi.2022.10.3.014.
Texto completo da fontePetering, Holger, Otto Götze, Daniela Kimmig, Regina Smolarski, Alexander Kapp e Jörn Elsner. "The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils". Blood 93, n.º 2 (15 de janeiro de 1999): 694–702. http://dx.doi.org/10.1182/blood.v93.2.694.
Texto completo da fontePetering, Holger, Otto Götze, Daniela Kimmig, Regina Smolarski, Alexander Kapp e Jörn Elsner. "The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils". Blood 93, n.º 2 (15 de janeiro de 1999): 694–702. http://dx.doi.org/10.1182/blood.v93.2.694.402k31_694_702.
Texto completo da fonteLe Naour, Augustin, Mélissa Prat, Benoît Thibault, Renaud Mével, Léa Lemaitre, Hélène Leray, Marie-Véronique Joubert et al. "Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors". Journal of Molecular Cell Biology 12, n.º 3 (3 de setembro de 2019): 202–15. http://dx.doi.org/10.1093/jmcb/mjz090.
Texto completo da fonteТаганович, А. Д., Н. Н. Ковганко, Г. Л. Гуревич, Г. К. Новская, О. А. Будник, О. В. Готько e В. И. Прохорова. "Verification of Blood Inflammatory Biomarkers Changes in the Diagnosis of Non-Small Cell Lung Cancer". Евразийский онкологический журнал 12, n.º 1 (25 de março de 2024): 64–72. http://dx.doi.org/10.34883/pi.2024.12.1.024.
Texto completo da fonteCho, Hee Seong, Young In Choi, Seon Uk Park, Yi Seul Han, Jean Kwon e Sung Jun Jung. "Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2". International Journal of Molecular Sciences 24, n.º 3 (17 de janeiro de 2023): 1855. http://dx.doi.org/10.3390/ijms24031855.
Texto completo da fonteXing, Dongqi, J. Michael Wells, Samantha S. Giordano, Wenguang Feng, Amit Gaggar, Jie Yan, Fadi G. Hage, Li Li, Yiu-Fai Chen e Suzanne Oparil. "Induced pluripotent stem cell-derived endothelial cells attenuate lipopolysaccharide-induced acute lung injury". Journal of Applied Physiology 127, n.º 2 (1 de agosto de 2019): 444–56. http://dx.doi.org/10.1152/japplphysiol.00587.2018.
Texto completo da fonteWolf, Marlene, Maria Belen Delgado, Simon A. Jones, Beatrice Dewald, Ian Clark-Lewis e Marco Baggiolini. "Granulocyte chemotactic protein 2 acts via both IL- 8 receptors, CXCR1 and CXCR2". European Journal of Immunology 28, n.º 1 (janeiro de 1998): 164–70. http://dx.doi.org/10.1002/(sici)1521-4141(199801)28:01<164::aid-immu164>3.0.co;2-s.
Texto completo da fonteLiu, Qian, Anping Li, Yijun Tian, Jennifer D. Wu, Yu Liu, Tengfei Li, Yuan Chen, Xinwei Han e Kongming Wu. "The CXCL8-CXCR1/2 pathways in cancer". Cytokine & Growth Factor Reviews 31 (outubro de 2016): 61–71. http://dx.doi.org/10.1016/j.cytogfr.2016.08.002.
Texto completo da fonteBlaser, Bradley Wayne, Jessica Moore, Brian LI, Owen J. Tamplin, Vera Binder e Leonard I. Zon. "IL-8 and CXCR1 Remodel the Vascular Niche to Promote Hematopoietic Stem and Progenitor Cell Engraftment". Blood 126, n.º 23 (3 de dezembro de 2015): 783. http://dx.doi.org/10.1182/blood.v126.23.783.783.
Texto completo da fontePenco-Campillo, Manon, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco et al. "Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas". Cells 11, n.º 23 (5 de dezembro de 2022): 3933. http://dx.doi.org/10.3390/cells11233933.
Texto completo da fonteLee, Kyung-Soon, Edelmar Navaluna, Nicole M. Marsh, Eric M. Janezic e Chris Hague. "Development of a Novel SNAP-Epitope Tag/Near-Infrared Imaging Assay to Quantify G Protein-Coupled Receptor Degradation in Human Cells". SLAS DISCOVERY: Advancing the Science of Drug Discovery 26, n.º 4 (5 de janeiro de 2021): 570–78. http://dx.doi.org/10.1177/2472555220979793.
Texto completo da fonteLaura, Brandolini, Benedetti Elisabetta, Ruffini Pier Adelchi, Russo Roberto, Cristiano Loredana, Antonosante Andrea, d’Angelo Michele et al. "CXCR1/2 pathways in paclitaxel-induced neuropathic pain". Oncotarget 8, n.º 14 (20 de fevereiro de 2017): 23188–201. http://dx.doi.org/10.18632/oncotarget.15533.
Texto completo da fontePawlick, Rena L., John Wink, Andrew R. Pepper, Antonio Bruni, Nasser Abualhassen, Yasmin Rafiei, Boris Gala-Lopez, Mariusz Bral e A. M. James Shapiro. "Reparixin, a CXCR1/2 inhibitor in islet allotransplantation". Islets 8, n.º 5 (21 de junho de 2016): 115–24. http://dx.doi.org/10.1080/19382014.2016.1199303.
Texto completo da fonteLima, Leonardo R. de, Heloisa M. F. Mendes, Frederico M. Soriani, Danielle G. de Souza, Geraldo Eleno S. Alves, Mauro M. Teixeira e Rafael R. Faleiros. "Histologic and inflammatory lamellar changes in horses with oligofructose-induced laminitis treated with a CXCR1/2 antagonist". Pesquisa Veterinária Brasileira 36, n.º 1 (janeiro de 2016): 13–18. http://dx.doi.org/10.1590/s0100-736x2016000100002.
Texto completo da fonteHenrot, Pauline, Renaud Prevel, Patrick Berger e Isabelle Dupin. "Chemokines in COPD: From Implication to Therapeutic Use". International Journal of Molecular Sciences 20, n.º 11 (6 de junho de 2019): 2785. http://dx.doi.org/10.3390/ijms20112785.
Texto completo da fonteGhasemzadeh, Mehran, Zane S. Kaplan, Imala Alwis, Simone M. Schoenwaelder, Katrina J. Ashworth, Erik Westein, Ehteramolsadat Hosseini et al. "The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi". Blood 121, n.º 22 (30 de maio de 2013): 4555–66. http://dx.doi.org/10.1182/blood-2012-09-459636.
Texto completo da fonteWong, Yin Ping, Noorhafizah Wagiman, Jonathan Wei De Tan, Barizah Syahirah Hanim, Muhammad Syamil Hilman Rashidan, Kai Mun Fong, Naufal Naqib Norhazli et al. "Loss of CXC-Chemokine Receptor 1 Expression in Chorioamnionitis Is Associated with Adverse Perinatal Outcomes". Diagnostics 12, n.º 4 (1 de abril de 2022): 882. http://dx.doi.org/10.3390/diagnostics12040882.
Texto completo da fonteMekhloufi, Abdelilah, Andrea Kosta, Helena Stabile, Rosa Molfetta, Alessandra Zingoni, Alessandra Soriani, Marco Cippitelli et al. "Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor". Cancers 12, n.º 2 (13 de fevereiro de 2020): 440. http://dx.doi.org/10.3390/cancers12020440.
Texto completo da fonteLippert, Undine, Metin Artuc, Andreas Grützkau, Annelie Möller, Anna Kenderessy-Szabo, Dirk Schadendorf, Johannes Norgauer et al. "Expression and Functional Activity of the IL-8 Receptor Type CXCR1 and CXCR2 on Human Mast Cells". Journal of Immunology 161, n.º 5 (1 de setembro de 1998): 2600–2608. http://dx.doi.org/10.4049/jimmunol.161.5.2600.
Texto completo da fonteCastelli, Vanessa, Laura Brandolini, Michele d’Angelo, Cristina Giorgio, Margherita Alfonsetti, Pasquale Cocchiaro, Francesca Lombardi, Annamaria Cimini e Marcello Allegretti. "CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling". Cells 10, n.º 9 (6 de setembro de 2021): 2324. http://dx.doi.org/10.3390/cells10092324.
Texto completo da fonteCitro, Antonio, Elisa Cantarelli, Paola Maffi, Rita Nano, Raffaella Melzi, Alessia Mercalli, Erica Dugnani et al. "CXCR1/2 inhibition enhances pancreatic islet survival after transplantation". Journal of Clinical Investigation 122, n.º 10 (1 de outubro de 2012): 3647–51. http://dx.doi.org/10.1172/jci63089.
Texto completo da fonteLima, Leonardo R., Heloisa M. Falcão Mendes, Frederico M. Soriani, Geraldo Eleno S. Alves, Danielle G. de Souza, Mauro M. Teixeira e Rafael R. Faleiros. "Reparixin, an antagonist of CXCR1/2, in experimental laminitis". Journal of Equine Veterinary Science 33, n.º 10 (outubro de 2013): 871–72. http://dx.doi.org/10.1016/j.jevs.2013.08.055.
Texto completo da fonteLu, Min, Lijuan Xia, Mohamed E. Salama e Ronald Hoffman. "Enriched Populations of Human Megakaryocytic Cells Affect the Behavior of Myelofibrosis CD34+ Cells As Well As Cells Belonging to the MF Supportive Microenvironment". Blood 132, Supplement 1 (29 de novembro de 2018): 3057. http://dx.doi.org/10.1182/blood-2018-99-117062.
Texto completo da fonteArmstrong, Chris, Jonathan Coulter, Pamela Maxwell, Silvia Berlingeri, Joe M. O'Sullivan, Kevin Prise e David J. Waugh. "Sensitivity of PTEN-deficient prostate carcinoma cells to ionizing radiation through inhibition of treatment-induced CXCL8 signaling." Journal of Clinical Oncology 31, n.º 6_suppl (20 de fevereiro de 2013): 154. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.154.
Texto completo da fonteKaur, Manpreet, Ramneek, C. S. Mukhopadhyay e Jaspreet Singh Arora. "PCR-SSCP and Sequencing of CXCR1 (IL8RA) Gene in Indian Water Buffalo". International Journal of Applied Sciences and Biotechnology 4, n.º 2 (27 de junho de 2016): 228–32. http://dx.doi.org/10.3126/ijasbt.v4i2.15128.
Texto completo da fonteRuffini, P. A., L. Brandolini, R. Russo, A. Cimini e M. Allegretti. "CXCR1/2 inhibition prevents paclitaxel- and oxaliplatin-induced peripheral neuropathy". European Journal of Cancer 69 (dezembro de 2016): S115. http://dx.doi.org/10.1016/s0959-8049(16)32943-4.
Texto completo da fonteCarreira, E. U., V. Carregaro, M. M. Teixeira, A. Moriconi, A. Aramini, W. A. Verri, S. H. Ferreira, F. Q. Cunha e T. M. Cunha. "Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain". European Journal of Pain 17, n.º 5 (7 de novembro de 2012): 654–63. http://dx.doi.org/10.1002/j.1532-2149.2012.00240.x.
Texto completo da fonteHuang, Yunjia, Jichen Yang, Yong Zhang, Shuhong Kuang, Zongshan Shen e Wei Qin. "Blocking CXCR1/2 attenuates experimental periodontitis by suppressing neutrophils recruitment". International Immunopharmacology 128 (fevereiro de 2024): 111465. http://dx.doi.org/10.1016/j.intimp.2023.111465.
Texto completo da fonteFlorey, Oliver J., Michael Johns, Olubukola O. Esho, Justin C. Mason e Dorian O. Haskard. "Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between FcγRIIa and CXCR1/2". Blood 109, n.º 9 (23 de janeiro de 2007): 3881–89. http://dx.doi.org/10.1182/blood-2006-08-044669.
Texto completo da fonte